Skip to main content
SpringerLink
Log in

Trastuzumab in metastatic HER2+ breast cancer: cardiotoxicity

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Calvillo-Arguelles O, et al. Trastuzumab-Related Cardiotoxicity and Cardiac Care in Patients With HER2 Positive Metastatic Breast Cancer. American Journal of Cardiology : 27 Jan 2020. Available from: URL: http://doi.org/10.1016/j.amjcard.2020.01.029

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trastuzumab in metastatic HER2+ breast cancer: cardiotoxicity. Reactions Weekly 1794, 12 (2020). https://doi.org/10.1007/s40278-020-75808-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-75808-7

Search

Navigation